SELLAS Life Sciences (SLS) Enterprise Value (2010 - 2026)
SELLAS Life Sciences (SLS) reported Enterprise Value of -$100000.0 for Q1 2026, little changed year-over-year from -$100000.0 in Q1 2025, and little changed quarter-over-quarter from -$100000.0 in Q4 2025.
SELLAS Life Sciences (SLS) Enterprise Value (2010 - 2026) Analysis & Trends
SELLAS Life Sciences (SLS) has 17 years of Enterprise Value data on file, last reported at -$100000.0 in Q1 2026.
- Enterprise Value for Q1 2026 came in at -$100000.0, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$100000.0 (changed 0.0% YoY), and the FY2025 annual result was -$100000.0, up 99.28% from the prior year.
- Enterprise Value was little changed at -$100000.0 in Q1 2026 per SLS's latest filing, from -$100000.0 in the prior quarter.
- Over five years, Enterprise Value peaked at -$100000.0 in Q1 2022 and troughed at -$44.3 million in Q3 2025.
- A 5-year average of -$6.3 million and a median of -$100000.0 in 2022 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2022 and 2025: Enterprise Value soared 99.64% in 2022, then slumped 44220.0% in 2025.
- A 5-year view of Enterprise Value shows it stood at -$17.1 million in 2022, then jumped by 85.23% to -$2.5 million in 2023, then plunged by 448.85% to -$13.9 million in 2024, then soared by 99.28% to -$100000.0 in 2025, then changed by 0.0% to -$100000.0 in 2026.
- Business Quant data shows SLS's Enterprise Value at -$100000.0 in Q1 2026, -$100000.0 in Q4 2025, and -$44.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -584.73 Mn |
| 10 | SELLAS Life Sciences | 1.39 Bn | 1.39 Bn | - | -100,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -100,000.00 |
| Dec 31, 2025 | -100,000.00 |
| Sep 30, 2025 | -44.32 Mn |
| Jun 30, 2025 | -100,000.00 |
| Mar 31, 2025 | -100,000.00 |
| Dec 31, 2024 | -13.89 Mn |
| Sep 30, 2024 | -100,000.00 |
| Jun 30, 2024 | -100,000.00 |
| Mar 31, 2024 | -100,000.00 |
| Dec 31, 2023 | -2.53 Mn |
| Sep 30, 2023 | -3.97 Mn |
| Jun 30, 2023 | -100,000.00 |
| Mar 31, 2023 | -23.90 Mn |
| Dec 31, 2022 | -17.13 Mn |
| Sep 30, 2022 | -100,000.00 |
| Jun 30, 2022 | -100,000.00 |
| Mar 31, 2022 | -100,000.00 |
| Dec 31, 2021 | -21.36 Mn |
| Sep 30, 2021 | -26.30 Mn |
| Jun 30, 2021 | -100,000.00 |